Cargando…

Epigenetics and Disease Pharmaceutical Opportunities /

Epigenetics has emerged recently as an important area of molecular biological studies. Epigenetic modifications lead to potentially heritable but reversible alterations in the expression of genes that determine cell fate. Epigenetic misregulation is thus often linked to degenerative diseases, cancer...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Gasser, Susan M. (Editor ), Li, En (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Basel : Springer Basel : Imprint: Springer, 2011.
Edición:1st ed. 2011.
Colección:Progress in Drug Research, 67
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-7643-8989-5
003 DE-He213
005 20220118234836.0
007 cr nn 008mamaa
008 101029s2011 sz | s |||| 0|eng d
020 |a 9783764389895  |9 978-3-7643-8989-5 
024 7 |a 10.1007/978-3-7643-8989-5  |2 doi 
050 4 |a RB155-155.8 
072 7 |a MFN  |2 bicssc 
072 7 |a MED107000  |2 bisacsh 
072 7 |a MFN  |2 thema 
082 0 4 |a 616.042  |2 23 
245 1 0 |a Epigenetics and Disease  |h [electronic resource] :  |b Pharmaceutical Opportunities /  |c edited by Susan M. Gasser, En Li. 
250 |a 1st ed. 2011. 
264 1 |a Basel :  |b Springer Basel :  |b Imprint: Springer,  |c 2011. 
300 |a X, 270 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Progress in Drug Research,  |x 2297-4555 ;  |v 67 
505 0 |a DNA Methylation and Cancer -- Genome-wide Epigenetic Modifications in Cancer -- DNA Repair and the Control of DNA Methylation -- Errors in Erasure: Links Between Histone lysine Methylation Removal and Disease -- Histone Modifications in Cancer Biology and Prognosis -- Dynamics of Histone Lysine Methylation: Structures of Methyl Writers and Eraser -- Epigenetic Mechanisms of Mental Retardation -- Histone and DNA Modifications in Mental Retardation -- HDAC Inhibitors and Cancer Therapy -- Epigenetic Mechanisms in Acute Myeloid Leukemia -- The Liver-Specific MicroRNA miR-122: Biology and Therapeutic Potential -- Witold Filipowicz and Helge Großhans -- Transcriptional Regulatory Networks in Embryonic Stem Cells -- Small Molecules in Cellular Reprogramming and Differentiation. 
520 |a Epigenetics has emerged recently as an important area of molecular biological studies. Epigenetic modifications lead to potentially heritable but reversible alterations in the expression of genes that determine cell fate. Epigenetic misregulation is thus often linked to degenerative diseases, cancer and neuronal disorders. Recent biomedical interest in this regulatory system stems from the fact that epigenetic, in contrast to genetic, alterations are in principle amenable to pharmacological intervention. A few epigenetically active drugs, for example histone deacetylase inhibitors (HDACi) and DNA methyltransferase (DNMT) inhibitors, have been approved by FDA for treatment of cancers such as CTCL, MDS, and AML. This volume explores the scientific background for clinical applications of epigenetically active drugs. Included are descriptions of epigenetic controls over gene expression, the post-transcriptional silencing of genes by RNA interference (RNAi) and microRNAs, as well as new findings from stem cell research which are relevant to pharmacological applications. 
650 0 |a Medical genetics. 
650 1 4 |a Medical Genetics. 
700 1 |a Gasser, Susan M.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Li, En.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783764389888 
776 0 8 |i Printed edition:  |z 9783764399146 
776 0 8 |i Printed edition:  |z 9783034803052 
830 0 |a Progress in Drug Research,  |x 2297-4555 ;  |v 67 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-7643-8989-5  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)